Fig. 3
From: A genomic mutation spectrum of collecting duct carcinoma in the Chinese population
CDKN2A alteration is important in CDC and associated TCGA cohorts. A Components of single-nucleotide variants (SNV, green), copy number variants (CNV, orange), combinations of SNV and CNV (red), and wild-type (WT, blue) CDKN2A in different kinds of carcinomas (from left to right: CDC, BLCA, KIRC, KIRP and BRCA, respectively). B Lollipop plots of CDKN2A somatic variant mutation in different kinds of carcinomas. C Overall survival of patients with BLCA, BRCA, KIRC and KIRP between CDKN2A-altered and wild-type (WT) groups. KIRC, clear cell renal cell carcinoma; KIRP, papillary renal cell carcinoma; BLCA, bladder carcinoma; CDC, collecting duct carcinoma; BRCA, breast cancer